- Home
- AZZ vs NEO Comparison
AZZ vs NEO Comparison
Compare AZZ & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZZ
- NEO
- Stock Information
- Founded
- AZZ 1956
- NEO 2001
- Country
- AZZ United States
- NEO United States
- Employees
- AZZ N/A
- NEO N/A
- Industry
- AZZ Industrial Specialties
- NEO Precision Instruments
- Sector
- AZZ Industrials
- NEO Health Care
- Exchange
- AZZ Nasdaq
- NEO Nasdaq
- Market Cap
- AZZ 2.3B
- NEO 2.1B
- IPO Year
- AZZ N/A
- NEO 1999
- Fundamental
- Price
- AZZ $82.98
- NEO $15.04
- Analyst Decision
- AZZ Buy
- NEO Strong Buy
- Analyst Count
- AZZ 6
- NEO 9
- Target Price
- AZZ $95.80
- NEO $19.89
- AVG Volume (30 Days)
- AZZ 155.9K
- NEO 792.3K
- Earning Date
- AZZ 01-07-2025
- NEO 11-05-2024
- Dividend Yield
- AZZ 0.82%
- NEO N/A
- EPS Growth
- AZZ 17.78
- NEO N/A
- EPS
- AZZ 1.08
- NEO N/A
- Revenue
- AZZ $1,570,389,000.00
- NEO $644,118,000.00
- Revenue This Year
- AZZ $4.77
- NEO $12.93
- Revenue Next Year
- AZZ $5.34
- NEO $9.70
- P/E Ratio
- AZZ $76.44
- NEO N/A
- Revenue Growth
- AZZ 4.75
- NEO 12.06
- 52 Week Low
- AZZ $48.03
- NEO $12.77
- 52 Week High
- AZZ $88.67
- NEO $21.22
- Technical
- Relative Strength Index (RSI)
- AZZ 55.71
- NEO 52.58
- Support Level
- AZZ $82.81
- NEO $13.35
- Resistance Level
- AZZ $87.15
- NEO $16.60
- Average True Range (ATR)
- AZZ 2.32
- NEO 0.67
- MACD
- AZZ 0.48
- NEO 0.18
- Stochastic Oscillator
- AZZ 62.30
- NEO 53.98
About AZZ AZZ Inc.
AZZ Inc is a provider of galvanizing and a variety of metal coating solutions and coil coating solutions to a broad range of end markets in North America. In its Metal Coatings segment, the company offers metal finishing services to protect against corrosion, such as hot dip galvanizing, spin galvanizing, powder coating, anodizing, and plating. The Precoat Metals Segment offers aesthetic and corrosion-resistant coatings for steel and aluminum coils.
About NEO NeoGenomics Inc.
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.